Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey
Sara Tomczyk(Robert Koch Institute), Tim Eckmanns(Robert Koch Institute), Siddhartha Thakur(North Carolina State University), John Stelling(Brigham and Women's Hospital), René S. Hendriksen(European Union), Angelina Taylor(Robert Koch Institute), Aiman El‐Saed(University of Pittsburgh), Ann Christin Vietor(Robert Koch Institute), Megan E. Jacob(North Carolina State University), Dawn Sievert(Centers for Disease Control and Prevention), Allison C. Brown(McMaster University), Olga Perovic(University of the Witwatersrand), Sonja Löfmark(Public Health Agency of Sweden), Marlieke E.A. de Kraker(University Medical Center Groningen), Nandini Shetty(Public Health England), Rachel M. Smith(Centers for Disease Control and Prevention), Majid M. Alshamrani(King Abdulaziz Medical City)
Cited by 182
Related Papers
Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014
|Infection Control and Hospital Epidemiology|2016|1.3k
Global monitoring of antimicrobial resistance based on metagenomics analyses of urban sewage
|Nature Communications|2019|1.2k
Multiplex PCR for detection of plasmid-mediated colistin resistance determinants, mcr-1, mcr-2, mcr-3, mcr-4 and mcr-5 for surveillance purposes
|Eurosurveillance|2018|677
National Healthcare Safety Network (NHSN) report, data summary for 2012, Device-associated module
|American Journal of Infection Control|2013|658
Effect of Abolishment of the Use of Antimicrobial Agents for Growth Promotion on Occurrence of Antimicrobial Resistance in Fecal Enterococci from Food Animals in Denmark
|Antimicrobial Agents and Chemotherapy|2001|653